MX389787B - Composiciones generadoras de gasotransmisores electroquímicos y sus métodos de uso y apósitos y sistemas de tratamiento que los incorporan. - Google Patents

Composiciones generadoras de gasotransmisores electroquímicos y sus métodos de uso y apósitos y sistemas de tratamiento que los incorporan.

Info

Publication number
MX389787B
MX389787B MX2019009384A MX2019009384A MX389787B MX 389787 B MX389787 B MX 389787B MX 2019009384 A MX2019009384 A MX 2019009384A MX 2019009384 A MX2019009384 A MX 2019009384A MX 389787 B MX389787 B MX 389787B
Authority
MX
Mexico
Prior art keywords
methods
compositions
gasotransmitter
dressings
incorporate
Prior art date
Application number
MX2019009384A
Other languages
English (en)
Other versions
MX2019009384A (es
Inventor
Alan Willey
Stevan Samuel
Original Assignee
Noxsano Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noxsano Inc filed Critical Noxsano Inc
Publication of MX2019009384A publication Critical patent/MX2019009384A/es
Publication of MX389787B publication Critical patent/MX389787B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/01—Non-adhesive bandages or dressings
    • A61F13/01008—Non-adhesive bandages or dressings characterised by the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B17/00—Sulfur; Compounds thereof
    • C01B17/48—Sulfur dioxide; Sulfurous acid
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B21/00—Nitrogen; Compounds thereof
    • C01B21/20—Nitrogen oxides; Oxyacids of nitrogen; Salts thereof
    • C01B21/50—Nitrous acid; Salts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen composiciones que comprenden un mediador electroquímico orgánico y una sal de gasotransmisor que se convierte en un gasotransmisor mediante transferencia de electrones. También se describen vendajes y apósitos para heridas que comprenden los gasotransmisores sujetos, y métodos para fabricar un gasotransmisor, que comprenden exponer 5 las composiciones a un voltaje suficiente para reducir el mediador orgánico soluble en agua. Además, se describen métodos para tratar una variedad de estados de trauma y enfermedad aplicando una cantidad terapéuticamente efectiva de al menos un gasotransmisor a los mismos, y métodos para generar una dosis efectiva del gasotransmisor generado a partir de una reacción electrolítica que involucra las composiciones generadoras de gasotransmisores.
MX2019009384A 2017-02-09 2018-01-18 Composiciones generadoras de gasotransmisores electroquímicos y sus métodos de uso y apósitos y sistemas de tratamiento que los incorporan. MX389787B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762457039P 2017-02-09 2017-02-09
PCT/US2018/014265 WO2018147986A1 (en) 2017-02-09 2018-01-18 Electrochemical gasotransmitter generating compositions and methods of using same and dressings and treatment systems incorporating same

Publications (2)

Publication Number Publication Date
MX2019009384A MX2019009384A (es) 2019-12-11
MX389787B true MX389787B (es) 2025-03-19

Family

ID=63038868

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019009384A MX389787B (es) 2017-02-09 2018-01-18 Composiciones generadoras de gasotransmisores electroquímicos y sus métodos de uso y apósitos y sistemas de tratamiento que los incorporan.

Country Status (14)

Country Link
US (1) US10342706B2 (es)
EP (1) EP3579888B1 (es)
JP (1) JP6989157B2 (es)
KR (1) KR102189597B1 (es)
CN (1) CN110461374B (es)
AU (1) AU2018218200B2 (es)
CA (1) CA3053141A1 (es)
CL (1) CL2019002220A1 (es)
ES (1) ES2965705T3 (es)
IL (1) IL268577B (es)
MX (1) MX389787B (es)
PL (1) PL3579888T3 (es)
WO (1) WO2018147986A1 (es)
ZA (1) ZA201905431B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190328774A1 (en) * 2017-02-09 2019-10-31 Noxsano Inc. Electrochemical gasotransmitter generating compositions and methods of using same and dressings and treatment systems incorporating same
KR20210006384A (ko) 2018-04-25 2021-01-18 녹사노 아이엔씨. 광활성화 기체 신호 전달물질 생성 조성물
EP3804731A4 (en) * 2018-06-08 2022-04-06 Sumitomo Seika Chemicals Co., Ltd. COMPOSITION FOR SKIN WOUNDS
WO2019235165A1 (ja) 2018-06-08 2019-12-12 住友精化株式会社 炎症性消化器官疾患用組成物
AU2020211392A1 (en) * 2019-01-11 2021-07-22 Noxsano Inc. Electrochemical gasotransmitter generating compositions and bimetallic cells for the generation of gasotransmitters
TWI694844B (zh) * 2019-01-29 2020-06-01 明基材料股份有限公司 硫化氫緩釋敷料及其製造方法
CN109793919B (zh) * 2019-02-01 2022-01-14 明基材料（芜湖）有限公司 硫化氢缓释敷料及其制造方法
JP2023510661A (ja) * 2019-06-04 2023-03-15 サーティー ホールディングス リミテッド 窒素酸化物を生成するための方法及び組成物、並びにそれらの使用
JP7686578B2 (ja) * 2019-06-04 2025-06-02 サーティー レスピラトリー リミテッド 窒素酸化物を生成するための方法および組成物、ならびに気道を介して窒素酸化物を送達するためのそれらの使用
WO2021152504A1 (en) * 2020-01-30 2021-08-05 3M Innovative Properties Company Delivery system for aqueous zinc oral care compositions with fluoride
CN115382095B (zh) * 2022-08-21 2025-08-08 兰州理工大学 超级电容器、应用超级电容器的伤口敷料，以及制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5797887A (en) * 1996-08-27 1998-08-25 Novovasc Llc Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
US20090036516A1 (en) * 2003-01-13 2009-02-05 Ctg Pharma S.R.L. Compounds for treating metabolic syndrome
AU2007303050B2 (en) * 2006-10-05 2013-11-07 Fred Hutchinson Cancer Research Center Liquid chalcogenide compositions and methods of manufacturing and using the same
EP2300604A4 (en) * 2008-06-24 2011-07-27 Micropharma Ltd NITRIC OXIDE COMPOSITIONS AND APPARATUS AND METHOD FOR COSMESIS
US9511196B2 (en) * 2009-12-31 2016-12-06 Ohio University Systems and methods for promoting wound healing
WO2013039713A2 (en) * 2011-09-14 2013-03-21 3M Innovative Properties Company Positive pressure medical dressings with valve and kits containing same
CA2847589C (en) * 2011-09-14 2019-11-26 Nuevas Alternativas Naturales, S.A.P.I. de C.V. Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof
US9480785B2 (en) * 2012-03-30 2016-11-01 The Regents Of The University Of Michigan Nitric oxide delivery devices
CN104394923B (zh) * 2012-03-30 2017-07-14 密执安大学评议会 一氧化氮递送装置
BR102013022095A2 (pt) 2013-08-29 2016-08-02 Mineração Tabiporã Ltda processo para a obtenção de sulfeto de hidrogênio a partir da redução de sulfato de cálcio e da decomposição do sulfeto de cálcio com cloreto de magnésio
BR112016009986B1 (pt) * 2013-11-07 2020-12-29 Bsn Medical Gmbh emplastro médico e seu uso

Also Published As

Publication number Publication date
CL2019002220A1 (es) 2020-01-03
IL268577B (en) 2020-03-31
EP3579888A4 (en) 2021-04-07
CA3053141A1 (en) 2018-08-16
EP3579888A1 (en) 2019-12-18
ES2965705T3 (es) 2024-04-16
WO2018147986A1 (en) 2018-08-16
JP6989157B2 (ja) 2022-01-05
KR102189597B1 (ko) 2020-12-14
CN110461374A (zh) 2019-11-15
KR20190108169A (ko) 2019-09-23
US10342706B2 (en) 2019-07-09
IL268577A (en) 2019-09-26
CN110461374B (zh) 2022-05-31
JP2020511526A (ja) 2020-04-16
EP3579888B1 (en) 2023-09-27
MX2019009384A (es) 2019-12-11
ZA201905431B (en) 2020-05-27
BR112019016486A2 (pt) 2020-04-07
AU2018218200A1 (en) 2019-08-29
EP3579888C0 (en) 2023-09-27
PL3579888T3 (pl) 2024-05-27
AU2018218200B2 (en) 2023-11-23
US20180221210A1 (en) 2018-08-09

Similar Documents

Publication Publication Date Title
MX389787B (es) Composiciones generadoras de gasotransmisores electroquímicos y sus métodos de uso y apósitos y sistemas de tratamiento que los incorporan.
CO2020010552A2 (es) Compuestos
CY1126855T1 (el) Ενωσεις κυκλικων δινουκλεοτιδιων για τη θεραπευτικη αγωγη καρκινου
CO2021005987A2 (es) Compuestos de anillo fusionado
MX2020011564A (es) Analogos de rapamicina unidos a c26 como inhibidores de mtor.
ZA202001717B (en) Compounds, salts thereof and methods for treatment of diseases
MX2021007158A (es) Heteroarilamidas utiles como inhibidores de kif18a.
CO2021003036A2 (es) Compuestos de anillo fusionado
JOP20210244A1 (ar) مركبات وتركيبات وطرائق لمعالجة الأمراض
BR112017000470A2 (pt) composto, composição farmacêutica, método para modular atividade, método para tratar uma afecção
CR20200518A (es) Piridozinonas como inhibidores de parp7
CY1118894T1 (el) Προληψη αρνητικων επιδρασεων οι οποιες οφειλονται σε cd3 ειδικες επικρατειες δεσμευσης
CL2019003515A1 (es) Compuestos heteroaromáticos como inhibidores de vanina.
MX2019014041A (es) Inhibidores pirazolicos de magl.
CR20200334A (es) Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas
MX2021000295A (es) Compuestos inmunomoduladores dimericos contra mecanismos basados en cereblon.
CO2019005059A2 (es) Inhibidores de magl
BR112022023025A2 (pt) Moduladores de htt para tratar doença de huntington
MX2020006237A (es) Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4.
TR201818825T4 (tr) Kardi̇yak hi̇pertrofi̇ni̇n tedavi̇si̇ne ve tanisina yöneli̇k lncrnalar
CR20200214A (es) ALCOHOLES TERCIARIOS COMO INHIBIDORES DE PI3K-y
ECSP19084085A (es) Inhibidores pirazólicos de magl
MX2020000523A (es) Compuestos de isocromano y usos de los mismos.
DOP2021000071A (es) Compuestos heteroaromáticos como inhibidores de vanina
DOP2021000021A (es) Compuestos heteroaromáticos como inhibidores de vanina